How Cuozzo will impact the interplay between post grant proceedings and Hatch-Waxman litigation.
American University, Washington College of Law, Washington, DC, USA.|Global Pharma, Pillsbury Winthrop Shaw Pittman LLP, 1650 Tysons Boulevard, McLean, VA 22102, USA.
Natasha
N
Mishra
Global Pharma, Pillsbury Winthrop Shaw Pittman LLP, 1650 Tysons Boulevard, McLean, VA 22102, USA.
Patrick A
PA
Doody
Global Pharma, Pillsbury Winthrop Shaw Pittman LLP, 1650 Tysons Boulevard, McLean, VA 22102, USA.
Raj S
RS
Davé
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States
Cuozzo Speed Technologies; Hatch–Waxman Litigation and Inter Partes review; impact of Cuozzo on claim interpretation